Skip to main content

Original Research

Original Research
Chemotherapy-Induced Nausea and Vomiting: Optimizing Prevention and Management
Kamakshi V. Rao, PharmD, BCOP, CPP, Aimee Faso, PharmD, BCOP, CPP
Stakeholder Perspective
Selecting Best Therapies for Control of Chemotherapy-Induced Nausea and Vomiting
Read More
Original Research
Diabetes Medications and Cancer Risk: Review of the Literature
Lindsay Sanders, DO, MPH, Anu P. Michael, MD, Scott R. Anderson, MS IV, Loida D. Nguyen, PharmD, BCPS, Zackary A. Johnson, MS II, Quang T. Nguyen, DO, FACE, FTOS
Stakeholder Perspective
Cancer Risk Associated with Antidiabetes Medications: Implications for Patients, Providers, and Payers
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Original Research
Managing Hypertension in the Elderly: A Common Chronic Disease with Increasing Age
Scott R. Anderson, MS IV, Lindsay Sanders, DO, MPH, Loida D. Nguyen, PharmD, BCPS, Quang T. Nguyen, DO, FACE, FTOS
Stakeholder Perspective
Improving Hypertension Management in the Elderly a Core Clinical Goal
by Katrina Moore, PharmD
Read More
Original Research
Benefits of Novel Oral Anticoagulant Agents for Thromboprophylaxis after Total Hip or Knee Arthroplasty
Richard J. Friedman, MD, FRCSC
Stakeholder Perspective
A Paradigm Shift in Anticoagulation?
by Atheer A. Kaddis, PharmD
Read More
Original Research
Daily Average Consumption of 2 Long-Acting Opioids: An Interrupted Time Series Analysis
R. Amy Puenpatom, PhD, Sheryl L. Szeinbach, PhD, RPh, Larry Ma, PhD, Rami H. Ben-Joseph, PhD, Kent H. Summers, PhD, BSPharm
Stakeholder Perspective
Daily Average Consumption of 2 Long-Acting Opioids and Coverage Decisions
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Original Research
Impact of Treatment by NCQA-Certified Physicians on Diabetes-Related Outcomes
Brett Pinsky, MPH, James Harnett, PharmD, Ryne Paulose-Ram, PhD, Jack Mardekian, PhD, Navendu Samant, PhD, Kavita V. Nair, PhD
Stakeholder Perspective
What Certification Really Means for Physician Quality
by Walid F. Gellad, MD, MPH
Read More
Original Research
The Hickory Project: Controlling Healthcare Costs and Improving Outcomes for Diabetes Using the Asheville Project Model
Barry A. Bunting, PharmD, DSNAP, Grover Lee, PharmD, BCMCM, Grant Knowles, PharmD, Christine Lee, PharmD, BCPS, CLS, Paul Allen, PhD, MBA
Stakeholder Perspective
Keeping a Lid on Health Plan Costs, One Patient at a Time
by Rick Miller
Read More
Original Research
Obesity in the Workplace: Impact on Cardiovascular Disease, Cost, and Utilization of Care
Alberto M. Colombi, MD, MPH, G. Craig Wood, MS
Stakeholder Perspective
Employers’ Obesity Initiatives in the Workplace: A Wakeup Call for Health Plans
by Wayne M. Lednar, MD, PhD
Read More
Original Research
A Call to Action: Responding to the Future Forecasting of Cardiovascular Disease in America
Robert Lee Page ii, PharmD, MSPH, FAHA, FCCP, FASCcP, FASHP, BCPS, Vahram Ghushchyan, PhD, Kavita Nair, PhD
Stakeholder Perspective
Prevention Efforts before Disease Strikes the Key to a Healthy Population of Young Adults
by James T. Kenney, RPh, MBA
Read More
Original Research
Atypical Antipsychotics and Metabolic Syndrome in Patients with Schizophrenia: Risk Factors, Monitoring, and Healthcare Implications
Henry J. Riordan, PhD, Paola Antonini, MD, PhD, Michael F. Murphy, MD, PhD
Stakeholder Perspective
The Complexities of Treating Mental Illness
by Atheer A. Kaddis, PharmD
Read More
Page 17 of 21
Results 161 - 170 of 209